Continuation of clozapine during chemotherapy and a stem cell transplant | Zendy

Burlingham Amy | Zendy; Anandakumar Padmini | Zendy; Brownell Lisa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Continuation of clozapine during chemotherapy and a stem cell transplant

Author(s) -

Burlingham Amy,

Anandakumar Padmini,

Brownell Lisa

Publication year - 2016

Publication title -

progress in neurology and psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.19

H-Index - 12

eISSN - 1931-227X

pISSN - 1367-7543

DOI - 10.1002/pnp.434

Subject(s) - clozapine , medicine , multidisciplinary team , incidence (geometry) , chemotherapy , schizophrenia (object oriented programming) , continuation , psychiatry , intensive care medicine , nursing , physics , optics , computer science , programming language

Cancer incidence rates in the UK have increased by more than a third over the last four decades, so the likelihood of requiring concurrent chemotherapy and clozapine is increasing. In this situation clinicians are faced with a clinical conundrum: to stop clozapine and risk a psychotic relapse, or to continue clozapine and risk a potentially fatal agranulocytosis. This case report describes how a multidisciplinary team (MDT) worked together to balance the mental and physical health needs of a patient.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research